Because macrophages also express Arg1 and Slc6a8, a therapeutic substance that modulates arginine metabolism towards increases in Arg1 and Slc6a8, would be promising in the treatment of IBD. The gene discussed is SLC6A8; the disease is inflammatory bowel disease.